The Spine Journal
Volume 11, Issue 6 , Pages 560-567 , June 2011

Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion

  • Kamran Majid, MD

      Affiliations

    • Department of Orthopaedic Surgery, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Michael D. Tseng, MD

      Affiliations

    • Department of Orthopaedic Surgery, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Kevin C. Baker, MS

      Affiliations

    • Department of Orthopaedic Research, William Beaumont Hospital, Research Institute, Suite, Royal Oak, MI, USA
    • Corresponding Author InformationCorresponding author. Department of Orthopaedic Research, William Beaumont Hospital, Research Institute, Suite 404, 3601 West Thirteen Mile Rd, Royal Oak, MI 48073, USA. Tel.: (248) 551-9726; fax: (248) 551-0191.
    • ,
  • Alma Reyes-Trocchia, MD

      Affiliations

    • Department of Pathology, William Beaumont Hospital, Royal Oak, MI, USA
    • ,
  • Harry N. Herkowitz, MD

      Affiliations

    • Department of Orthopaedic Surgery, William Beaumont Hospital, Royal Oak, MI, USA

Received 14 July 2009 ,Revised 10 September 2009 ,Accepted 2 December 2009.

References 

  1. Rihn JA, Gates C, Glassman SD, et al. The use of bone morphogenetic protein in lumbar spine surgery. J Bone Joint Surg Am. 2008;90:2014–2025
  2. Kurz LT, Garfin SR, Booth RE. Harvesting autogenous iliac bone grafts. A review of complications and techniques. Spine. 1989;14:1324–1331
  3. Bridwell KH, Sedgewick TA, O'Brien MF, et al. The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis. J Spinal Disord. 1993;6:461–472
  4. McGuire RA, Amundson GM. The use of primary internal fixation in spondylolisthesis. Spine. 1993;18:1662–1672
  5. West JL, Bradford DS, Ogilvie JW. Results of spinal arthrodesis with pedicle screw-plate fixation. J Bone Joint Surg Am. 1991;73:1179–1184
  6. Zdeblick TA. A prospective, randomized study of lumbar fusion. Preliminary results. Spine. 1993;18:983–991
  7. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893–899
  8. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine. 2000;25:376–381
  9. Dimar JR, Glassman SD, Burkus KJ, Carreon LY. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine. 2006;31:2534–2539
  10. Glassman SD, Carreon L, Djurasovic M, et al. Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J. 2007;7:44–49
  11. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine. 2006;31:2813–2819
  12. McClellan JW, Mulconrey DS, Forbes RJ, Fullmer N. Vertebral resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech. 2006;19:483–486
  13. Joseph V, Rampersaud YR. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Spine. 2007;32:2885–2890
  14. Wong DA, Kumar A, Jatana S, et al. Neurologic impairment from ectopic bone in lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J. 2007;8:1011–1018
  15. Patel VV, Zhao L, Wong P, et al. Controlling bone morphogenetic protein 2 diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue. Spine. 2006;31:1201–1206
  16. Akamaru T, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery of recombinant bone morphogenetic protein-2 for posterolateral spinal fusion. Spine. 2003;28:429–434
  17. Liu Y, de Groot K, Hunziker EB. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone. 2005;36:745–757
  18. Baker KC, Anderson MA, Oehlke SA, et al. Growth, characterization and biocompatibility of bone-like calcium phosphate layers biomimetically deposited on metallic substrata. Mater Sci Eng C Biomim Mater Sens Syst. 2006;26:1351–1360
  19. Baker KC, Drelich J, Miskiouglu I, et al. Effect of polyethylene pretreatments on the biomimetic deposition and adhesion of calcium phosphate films. Acta Biomater. 2007;3:391–401
  20. Baker KC, Drelich J. Biomimetic formation of nano-crystalline calcium phosphate films on self-assembled monolayers of alkanethiols: effects of end functionality and deposition methodology. In:  Kellar JJ editors. Functional fillers and nano-scale minerals: new markets/new horizons. Littleton, CO: SME; 2006;p. 199–216
  21. Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model. Spine. 1995;20:412–420
  22. Singh K, Smucker JD, Ugbo JL, et al. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin. Spine J. 2007;7:326–331
  23. Suh DY, Boden SD, Louis-Ugbo J, et al. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine. 2002;27:353–360
  24. Sumner DR, Turner TM, Urban RM, et al. Locally delivered rhBMP-2 enhances hone ingrowth and gap healing in a canine model. J Orthop Res. 2004;22:58–65
  25. Glassman SD, Carreon LY, Campbell MJ, et al. The perioperative cost of infuse bone graft in posterolateral lumbar spine fusion. Spine J. 2008;8:443–448
  26. Wildemann B, Kadow-Romacker A, Lubberstedt M, et al. Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier. Calcif Tissue Int. 2005;76:50–55
  27. Koseki T, Gao Y, Okahashi N, et al. Role of TGF-beta family in osteoclastogenesis induced by RANKL. Cell Signal. 2002;14:31–36
  28. Kaneko H, Arakawa T, Mano H, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone. 2000;27:479–486

 FDA device/drug status: Not applicable (animal study).

 Author disclosures: KM: Nothing to disclose. MDT: Nothing to disclose. KCB: Nothing to disclose. AR-T: Nothing to disclose. HNH: Nothing to disclose.

 This work was funded by the William Beaumont Hospital Research Institute.

PII: S1529-9430(09)01120-6

doi: 10.1016/j.spinee.2009.12.006

The Spine Journal
Volume 11, Issue 6 , Pages 560-567 , June 2011

Article Tools

* Image Usage & Resolution